Safe and effective use of plerixafor plus G-CSF in dialysis-dependent renal failure

American Journal of Hematology

Volumn 85, Issue 6, 2010, Pages 461-462

  Pinto, Valeria ^a   Castelli, Andrea ^a   Gaidano, Gianluca ^a   Conconi, Annarita ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; PLERIXAFOR; THALIDOMIDE;

ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DIALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; KIDNEY FAILURE; LETTER; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; STEM CELL MOBILIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DEXAMETHASONE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HETEROCYCLIC COMPOUNDS; HUMANS; KIDNEY FAILURE, CHRONIC; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; MYELOABLATIVE AGONISTS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECEPTORS, CXCR4; RENAL DIALYSIS; THALIDOMIDE; TRANSPLANTATION CONDITIONING;

EID: 77953040054     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21712     Document Type: Letter

References (4)

1. Hatse S, Princen K, Bridger G, et al. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 2002;527:255-262. (Pubitemid 35253875)
2. DiPersio JF, Stadtmauer EA, Nademanee A, et al. Plerixafor and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood 2009;113:5720-5726.
3. DiPersio JF, Micallef IN, Stiff PJ, et al. Phase III prospective randomized double- blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. J Clin Oncol 2009;27:4767-4773.
4. Macfarland R, Hard ML, Scarborough R, et al. A pharmacokinetic study of plerixafor in subjects with varying degrees of renal impairment. Biol Blood Marrow Transplant 2010;16:95-101.